STOCK TITAN

Park Ha Biological changes independent auditor

Park Ha Biological Technology Co., Ltd. changed auditors, dismissing WWC, P.C. and appointing HTL INTERNATIONAL, LLC with no reported disagreements or reportable events.

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. (BYAH) replaced its independent registered public accounting firm, terminating WWC, P.C. on September 1, 2026 and appointing HTL INTERNATIONAL, LLC as the new auditor for its financial statements.

The company reports that WWC’s audit reports for the fiscal years ended October 31, 2025 and 2024 contained no adverse opinions, disclaimers, or qualifications, and that there were no disagreements or reportable events with WWC through the dismissal date. The change in auditor was recommended and approved by the Audit Committee and the Board of Directors.

Positive

  • None.

Negative

  • None.

Filing Explained

The filing additionally states that, before HTL’s engagement, neither the company nor anyone acting for it consulted HTL about accounting treatment, possible audit opinions, disagreements, or reportable events during the two most recent fiscal years or subsequent interim periods.

Auditor termination date September 1, 2026 Date WWC, P.C. was terminated as independent registered public accounting firm
New auditor appointment date September 1, 2026 Date HTL INTERNATIONAL, LLC was ratified as new independent registered public accounting firm
Fiscal year end October 31, 2025 Most recent fiscal year for which WWC, P.C. audited the company’s financial statements
Prior fiscal year end October 31, 2024 Earlier fiscal year covered by WWC, P.C. audit reports mentioned in the disclosure
Exhibit 16.1 date September 2, 2026 Date of WWC, P.C. letter filed as Exhibit 16.1
independent registered public accounting firm financial
"terminated its independent registered public accounting firm, WWC, P.C."
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
reportable events regulatory
"there were no “reportable events” as described in Item 16F(a)(1)(iv)"
Reportable events are significant incidents or changes a company is legally required to disclose to regulators and the public, such as major safety problems, legal actions, financial irregularities, or management changes. They matter to investors because these events can alter a company’s risk profile or future performance, much like a dashboard warning light signals a problem that could affect a car’s safety or reliability. Timely disclosure helps investors make informed decisions and maintain market fairness.
Audit Committee financial
"The decision to change the independent registered public accounting firm was recommended and approved by the Audit Committee"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Form 20-F regulatory
"as described in Item 16F(a)(1)(iv) of Form 20-F and related instructions"
Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.
Item 16F(a)(1)(iv) regulatory
"reportable events as described in Item 16F(a)(1)(iv) of Form 20-F"

FAQ

What auditor change did Park Ha Biological Technology Co., Ltd. (BYAH) disclose?

The company terminated WWC, P.C. as its independent registered public accounting firm on September 1, 2026 and on the same date the Audit Committee and Board ratified the appointment of HTL INTERNATIONAL, LLC as the new independent registered public accounting firm.

Were there any disagreements with WWC, P.C. reported by BYAH?

The company states that during the fiscal year ended October 31, 2025 and through September 1, 2026 there were no disagreements with WWC, P.C. on accounting principles, financial statement disclosure, or auditing scope or procedure and no reportable events.

How did WWC, P.C.’s prior audit opinions on BYAH’s financials read?

WWC, P.C.’s reports on the company’s financial statements for the fiscal years ended October 31, 2025 and 2024 contained no adverse opinion, no disclaimer of opinion, and no qualifications regarding uncertainty, audit scope, or accounting principles.

Who approved the change of auditor at Park Ha Biological Technology Co., Ltd. (BYAH)?

The decision to change the independent registered public accounting firm was recommended and approved by the company’s Audit Committee and its Board of Directors, according to the disclosure.

Did BYAH consult HTL INTERNATIONAL, LLC before its engagement as auditor?

The company reports that during the two most recent fiscal years ended October 31, 2025 and 2024 and subsequent interim periods, it did not consult HTL INTERNATIONAL, LLC on accounting principles, audit opinions, or matters involving disagreements or reportable events before HTL’s engagement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of September 2026

 

Commission File Number: 001-42453

 

Park Ha Biological Technology Co., Ltd.

 

901 & 902-2, Building C

Phase 2, Wuxi International Life Science Innovation Campus

196 Jinghui East Road

Xinwu District, Wuxi, Jiangsu Province

People’s Republic of China 214000

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 
 

 

Changes in Company’s Certifying Accountant.

 

(1) Previous Independent Registered Public Accounting Firm

 

(i) On September 1, 2026, Park Ha Biological Technology Co., Ltd. (the “Company”) terminated its independent registered public accounting firm, WWC, P.C. as the Company’s independent registered public accounting firm.

 

(ii) The report of WWC, P.C. on the financial statements of the Company for the fiscal years ended October 31, 2025 and 2024, and the related statements of operations and comprehensive income (loss), changes in stockholders’ equity (deficit), and cash flows for the fiscal years ended October 31, 2025 and 2024 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles.

 

(iii) The decision to change the independent registered public accounting firm was recommended and approved by the Audit Committee and Board of Directors of the Company.

 

(iv) During the Company’s most recent fiscal year ended October 31, 2025 and through September 1, 2026, the date of dismissal, (a) there were no disagreements with WWC, P.C. on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of WWC, P.C., would have caused it to make reference thereto in its reports on the financial statements for such years and (b) there were no “reportable events” as described in Item 16F(a)(1)(iv) of Form 20-F and related instructions to Item 16F of Form 20-F), or any reportable events (as described in Item 16F(a)(1)(v) of Form 20-F)

 

(2) New Independent Registered Public Accounting Firm

 

On September 1, 2026, the Audit Committee and the Company’s Board of Directors ratified the appointment of HTL INTERNATIONAL, LLC (“HTL”) as its new independent registered public accounting firm to audit and review the Company’s financial statements. During the two most recent fiscal years ended October 31, 2025 and 2024 and any subsequent interim periods through the date hereof prior to the engagement of HTL, neither the Company, nor someone on its behalf, has consulted HTL regarding:

 

(i) either: the application of accounting principles to a specified transaction, either completed or proposed; or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, and either a written report was provided to the Company or oral advice was provided that the new independent registered public accounting firm concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or

 

(ii) any matter that was either the subject of a disagreement as defined in paragraph Item 16F(a)(1)(iv) of Form 20-F and related instructions to Item 16F of Form 20-F), or any reportable events (as described in Item 16F(a)(1)(v) of Form 20-F)

 

The Company has provided A copy of WWC’s letter is filed hereto as Exhibit 16.1 to this Form 6-K.

 

 2 

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
     
Exhibit 16.1   Letter from WWC,P.C.,dated September 2, 2026.

 

 3 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Park Ha Biological Technology Co., Ltd.
     
Date: September 2, 2026 By: /s/ Xiaoqiu Zhang
  Name: Xiaoqiu Zhang
  Title: Chief Executive Officer, Chairperson of the Board of Directors

 

 4 

 

Filing Exhibits & Attachments

3 documents